Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07059832
PHASE1/PHASE2

Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors

Sponsor: First Hospital of China Medical University

View on ClinicalTrials.gov

Summary

This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the safety and clinical predictive value of 68Ga-NODAGA-SNA006 in subjects with solid tumor or lymphoma.

Official title: Application of 68Ga-NODAGA-SNA006 in Patients With Solid Tumor or Lymphoma

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2024-04-01

Completion Date

2028-04-01

Last Updated

2025-07-11

Healthy Volunteers

No

Conditions

Interventions

DRUG

68Ga-NODAGA-SNA006

68Ga-NODAGA-SNA006 PET/CT: after intravenous injection of 0.05 mCi/kg body weight of quality-controlled 68Ga-NODAGA-SNA006, an integrated PET/CT scanner (Biograph mCT; Siemens, Germany) will be applied.

Locations (1)

The First Hospital of China Medical University

Shenyang, Liaoning, China